2012 HIV Diagnostics Conference

December 12-14, 2012 Atlanta, Georgia

The 2012 HIV Diagnostics Conference, co-sponsored by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL), provides an opportunity for clinicians, clinical and public health laboratorians, HIV/AIDS program managers and directors, and industry representatives to review developments in HIV diagnostics, share data and research findings, and establish collaborations. Since its inception in 2005, the HIV Diagnostics Conference has served as an opportunity for those interested in issues related to HIV diagnostic testing to gather and discuss new developments and related prevention and surveillance measures.

At the 2010 HIV Diagnostics Conference, a new HIV-1/2 diagnostic testing algorithm was proposed. The 2012 HIV Diagnostics Conference will provide an opportunity for participants to share their experiences with 4th generation antigen/antibody assays and data generated with this new HIV-1/2 diagnostic testing algorithm. The 2012 conference will be held December 12-14 at the Sheraton Atlanta Hotel in Atlanta, GA. Online registration will open in February. The registration fee is $350. Registration, abstract submission and proceedings from past conferences can be accessed online. A limited number of scholarships are available to provide partial support for potential conference attendees who would otherwise be unable to participate.

A preconference workshop (included in the registration fee) will be held December 11 for interested program and laboratory personnel. Topics to be reviewed include HIV-related test principles, specimen selection and handling, measures of test performance, and understanding test kit product inserts. The HIV Diagnostic Conference Planning Committee actively encourages manufacturers of HIV diagnostic and prognostic assays or devices to participate in our Exhibitor Sessions and to contribute to the scientific discussion throughout the conference.